Clinical trials
Terminated Breast Carcinoma In Situ trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 3 |
| Jonsson Comprehensive Cancer Center | 2 |
| Roswell Park Cancer Institute | 2 |
| City of Hope Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| SWOG Cancer Research Network | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Carcinoma In Situ | 15 |
| Breast Neoplasms | 12 |
| Carcinoma, Intraductal, Noninfiltrating | 8 |
| Carcinoma, Ductal, Breast | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Carcinoma, Lobular | 1 |
| Fatigue | 1 |
| Fibrocystic Breast Disease | 1 |
| Hot Flashes | 1 |
| Precancerous Conditions | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.